1. Home
  2. ENTO vs TANH Comparison

ENTO vs TANH Comparison

Compare ENTO & TANH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENTO
  • TANH
  • Stock Information
  • Founded
  • ENTO 2014
  • TANH 2001
  • Country
  • ENTO United States
  • TANH China
  • Employees
  • ENTO N/A
  • TANH N/A
  • Industry
  • ENTO Biotechnology: Pharmaceutical Preparations
  • TANH
  • Sector
  • ENTO Health Care
  • TANH
  • Exchange
  • ENTO Nasdaq
  • TANH Nasdaq
  • Market Cap
  • ENTO 2.3M
  • TANH 2.6M
  • IPO Year
  • ENTO 2016
  • TANH 2015
  • Fundamental
  • Price
  • ENTO $4.16
  • TANH $1.83
  • Analyst Decision
  • ENTO
  • TANH
  • Analyst Count
  • ENTO 0
  • TANH 0
  • Target Price
  • ENTO N/A
  • TANH N/A
  • AVG Volume (30 Days)
  • ENTO 380.6K
  • TANH 1.7M
  • Earning Date
  • ENTO 11-12-2025
  • TANH 05-15-2025
  • Dividend Yield
  • ENTO N/A
  • TANH N/A
  • EPS Growth
  • ENTO N/A
  • TANH N/A
  • EPS
  • ENTO N/A
  • TANH N/A
  • Revenue
  • ENTO N/A
  • TANH $42,940,136.00
  • Revenue This Year
  • ENTO N/A
  • TANH N/A
  • Revenue Next Year
  • ENTO N/A
  • TANH N/A
  • P/E Ratio
  • ENTO N/A
  • TANH N/A
  • Revenue Growth
  • ENTO N/A
  • TANH N/A
  • 52 Week Low
  • ENTO $0.97
  • TANH $1.45
  • 52 Week High
  • ENTO $5.47
  • TANH $10.77
  • Technical
  • Relative Strength Index (RSI)
  • ENTO 62.56
  • TANH 45.64
  • Support Level
  • ENTO $4.70
  • TANH $1.62
  • Resistance Level
  • ENTO $5.47
  • TANH $1.96
  • Average True Range (ATR)
  • ENTO 0.54
  • TANH 0.14
  • MACD
  • ENTO -0.06
  • TANH -0.01
  • Stochastic Oscillator
  • ENTO 54.34
  • TANH 27.27

About ENTO Entero Therapeutics Inc. Common Stock

Entero Therapeutics Inc is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.

About TANH Tantech Holdings Ltd.

Tantech Holdings Ltd manufactures bamboo charcoal-based products. The company, through its subsidiaries, is engaged in the production and distribution of household products along with a trading business, which involves the export of charcoal products. It also manufactures electric double-layer capacitors carbon materials and low-emission barbecue charcoal. Its product portfolio includes air purifiers and humidifiers, underfloor humidity control, pillows and mattresses, wardrobe deodorizers, mousepads, and wrist mats, refrigerator deodorant, and charcoal toilet cleaner disks. The company has two reportable segments: the Consumer Product segment, and the Electric Vehicle (EV) segment.

Share on Social Networks: